Vitanova Life Sciences's ROA from the first quarter of 2026 to the first quarter of 2025 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics

What is Vitanova Life Sciences's ROA in the first quarter of 2026?
Vitanova Life Sciences Corp recorded a cumulative net loss of $0 million during 12 months ending in the first quarter of 2026, resulting in a negative return on assets (ROA) of -4.91%.

However, within the Consumer Discretionary sector VitaNova Life Sciences Corp achieved the highest return on assets. While return on assets, the total ranking has deteriorated compared to the fourth quarter of 2026 from 94 to 148.

What is ROA?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Assets ROA▼

None ▼

Return on Assets ROA▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Assets	(Jul 31 2026) I. Quarter	(Apr 30 2026) IV. Quarter	(Jan 31 2026) III. Quarter	(Oct 31 2025) II. Quarter	(Jul 31 2025) I. Quarter
Y / Y Total Assets Change	0.98 %	3.67 %	90.12 %	501.51 %	877.3 %
Y / Y Net Income Change	-	-97.81 %	-	9.82 %	-
Net Income (TTM) in million	0	0	1	1	1
Return On Assets (TTM)	-4.91 %	-1.61 %	32.45 %	42.51 %	55.86 %
VNOV's Total Ranking	# 148	# 94	# 77	# 80	# 290
Total Assets (TTM) in million	2	2	2	2	2
Seq. Total Assets Change	-8.47 %	8.43 %	-4.14 %	6.14 %	-6.03 %
Seq. Net Income Change	-	-	-	-	-

VNOV's 5 Years Annual ROA >> Back to VNOV Management Effectiveness >> Compare VNOV ROA to its Competitors

Return On Assets Company Ranking
Within:	No.
Industry	#
Sector	#
Overall	# 0

Return On Assets Statistics
High	Average	Low
57.59 %	-23.72 %	-208.46 %
(Apr 30 2025)		(Jul 31 2023)

Financial Statements
Vitanova Life Sciences's Assets	$ 2 million	VNOV's Balance sheet
Vitanova Life Sciences's Income	$ 0 million	Quarterly VNOV's Income Statement
VNOV's Income by Division		See VNOV's Income by Division

Annual Return On Assets	(Apr 30 2026) FY 2026	(Apr 30 2025) FY 2025	(Apr 30 2024) FY 2024	(Apr 30 2023) FY 2023	(Apr 30 2022) FY 2022
Y / Y Total Assets Change	3.67 %	98.85 %	13541.38 %	-62.34 %	-
Total Assets in million	2	2	1	0	0
Y / Y Net Income Change	-	503.76 %	-	-	-
Net Income in million	0	1	0	0	0
Annual Return On Assets	-1.52 %	36.05 %	11.87 %	-278.16 %	604.76 %

VNOV's 5 Years Annual ROA >> Back to VNOV Management Effectiveness >> Compare VNOV ROA to its Competitors

More Return On Assets Ratios
VNOV's' Return on Assets at Yahoo Finance
Apparel, Footwear & Accessories Industry Return On Assets Trends and Statistics
Consumer Discretionary Sector Roa Statistics
Roa Trends for overall market
VNOV's Roa Ratio versus Apparel, Footwear & Accessories Industry, Consumer Discretionary Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for VNOV's Competitors
Subscribers only: Roa for Vitanova Life Sciences's Suppliers
Subscribers only: Return On Assets for VNOV's Customers

You may also want to know
VNOV's Roi	VNOV's Inventory Turnover Ratio	VNOV's Growth Rates	VNOV's Dividend Comparisons
	VNOV's Profitability Ratios	VNOV's Asset Turnover Ratio	VNOV's Dividend Growth
VNOV's Roe	VNOV's Valuation Ratios	VNOV's Financial Strength Ratios	VNOV's Dividend Payout Ratio

Companies with similar Return On Assets at Jul 31 2026, within Consumer Discretionary Sector

ROA

Date modified: 2026-09-15T07:44:32+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.